drugset / Trial / NCT07594847
A Study of HDM1002 Tablets on Cardiac Repolarization in Healthy Subjects
RandomizedCrossoverDouble-blindTreatment
Summary
The aim of this trial is to evaluate the effect of a single oral dose of HDM1002 tablets on the QT/QTc interval in healthy subjects.
Timeline
- Start
- 2026-03-07
- Primary completion
- 2026-09-25
- Completion
- 2026-11-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HDM1002 | Unknown | 200 mg | Oral |
| Subject | HDM1002 | Unknown | 400 mg | Oral |
| Comparator | Moxifloxacin | Small molecule | 400 mg | Oral |
Indications
No indication recorded.